Organovo Exploring Strategic Alternatives After Poor Results
Company Suspended Development Of Its Lead Program
■ By JARED WHITLOCK
HEALTH CARE & LIFE SCIENCES
Organovo’s technology appears to be ripped from a science fiction novel: 3-D printed tissues that emulate human organs.
But financial difficulties have led the company to explore a merger, acquisition or other strategic alternatives.
On Aug. 7, San...
Read latest San Diego Business Journal online.
Online newspapers
at PressDisplay.